A Study to Evaluate the Pharmacokinetics of the CORT125134 Phase 2 Formulation in Healthy Male Subjects
Status:
Completed
Trial end date:
2016-04-27
Target enrollment:
Participant gender:
Summary
A study designed to characterize the pharmacokinetic (PK) profile of CORT125134 following a
single 150-mg oral dose of the Phase 2 capsule formulation of CORT125134 in 8 healthy male
subjects.